Rockefeller Capital Management’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Rockefeller Capital Management's KLRA Position: Q3 2026 in Review
Rockefeller Capital Management opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 1,000 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #4120 among its holdings.
132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Rockefeller Capital Management held 1,000 shares of Kailera Therapeutics worth $11.4K as of Q3 2026.
- Kailera Therapeutics was a new Rockefeller Capital Management position in Q3 2026.
- Kailera Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4120 holding.
- 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.